Drug
Diclofenac hydroxyethylpyrrolidine
Diclofenac hydroxyethylpyrrolidine is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_1
1
25%
Ph not_applicable
2
50%
Ph phase_4
1
25%
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
2 of 4 finished
Non-Completion Rate
50.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Terminated(2)
Detailed Status
Completed2
Withdrawn2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)
Trials by Status
completed250%
withdrawn250%
Recent Activity
0 active trials
Showing 4 of 4
withdrawnnot_applicable
Patient Preferences, Analgesic Delivery Method and Pain Reduction in Spine Patients
NCT01263652
completedphase_4
Safety Study of Flector Patch in Children With Minor Soft Tissue Injuries
NCT02132247
withdrawnnot_applicable
Efficacy of PENNSAID® for Pain Management in the Emergency Department
NCT01350622
completedphase_1
Diclofenac vs. Placebo in a Randomized Double Blind Controlled Trial in Post ERCP Pancreatitis
NCT01946984
Clinical Trials (4)
Showing 4 of 4 trials
NCT01263652Not Applicable
Patient Preferences, Analgesic Delivery Method and Pain Reduction in Spine Patients
NCT02132247Phase 4
Safety Study of Flector Patch in Children With Minor Soft Tissue Injuries
NCT01350622Not Applicable
Efficacy of PENNSAID® for Pain Management in the Emergency Department
NCT01946984Phase 1
Diclofenac vs. Placebo in a Randomized Double Blind Controlled Trial in Post ERCP Pancreatitis
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4